Get access to our best features
Get access to our best features
Published

U.S. FDA authorizes Pfizer's COVID booster shot for young children

Summary by Ground News
Pfizer requested this EUA at the end of April. Company data showed that a third vaccine dose raised Omicron-fighting antibodies by 36 times. 4,500 children ages 5 through 11 participated in the Pfizer/BioNTech Covid-19 vaccine trial.
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 61% of the sources are Center
60% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)